AstraZeneca acquires neuroscience assets from Link Medicine;
AstraZeneca today announced that it has acquired a portfolio of neuroscience assets from Link Medicine Corporation, a privately held biopharmaceutical company based in Massachusetts, USA.
DRUGS giant AstraZeneca has won a key US patent battle over its second-biggest selling drug, Seroquel, for schizophrenia and bipolar disorder.